Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
CO-AMOXICILLIN Sandoz 457 mg f Susp 35 ml
Drug
Co-Amoxicillin Sandoz 457 mg, Pulver zur Herstellung einer Suspension zum Einnehmen
Infektionskrankheiten
08.01.93 – combinations
HAM – Human medicine
PULS – Powder for oral suspension
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
5/11/2005
12/31/9999
Dosage strength
Co-Amoxicillin Sandoz 457, Pulver zur Herstellung einer Suspension zum Einnehmen
Infektionskrankheiten
01
Z – approved
Package
7680570460027
In trade from / since 5/11/2005
A/R – Authorised / referenced
35 ml
002
Z – approved
Declaration
Component
400 mg amoxicillinum anhydricum
amoxicillinum trihydricum
57 mg acidum clavulanicum
kalii clavulanas
amoxicillinum trihydricum
57 mg acidum clavulanicum
kalii clavulanas
silica colloidalis anhydrica
xanthani gummi
crospovidonum
carmellosum natricum
16.64 mg aspartamum
aromatica
alcohol benzylicus
propylenglycolum
max. 7.3 mg natrium
xanthani gummi
crospovidonum
carmellosum natricum
16.64 mg aspartamum
aromatica
alcohol benzylicus
propylenglycolum
max. 7.3 mg natrium
Spezialitätenliste***
SL
-
-
13.40
None
No
10%
Yes
Authorisation holder
7601001029439
Sandoz Pharmaceuticals AG
6343 Risch (ZG)
6343 Risch (ZG)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.